Inventor · disambiguated record
Takao Suzuki
Also filed as: SUZUKI TAKAO
22 granted patents·12 pending applications·46 citations·filing 2004–2022
92Inventor score
Files withMERCK SHARP & DOHME18BANYU PHARMA CO LTD4MERCK SHARP & DOHME LLC3ANDO MAKOTO2ASTELLAS PHARMA INC1
Top patents by PatentIndex Score
34 records- 0191US8952166B2Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2013·Granted Feb 10, 2015·17 cites·32 claims
- 0290US10947205B2Oxazolidinone compounds and methods of use thereof as antibacterial agentsMERCK SHARP & DOHME·Filed 2019·Granted Mar 16, 2021·5 cites·11 claims
- 0376US9839629B2Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2014·Granted Dec 12, 2017·3 cites·16 claims
- 0475US9862720B2Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2015·Granted Jan 9, 2018·2 cites·19 claims
- 0575US9850245B2Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2015·Granted Dec 26, 2017·2 cites·20 claims
- 0675US9206198B2Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2014·Granted Dec 8, 2015·2 cites·12 claims
- 0775US7504412B2Imidazopyridine derivativesBANYU PHARMA CO LTD·Filed 2004·Granted Mar 17, 2009·10 cites·18 claims
- 0874US9718808B2Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2015·Granted Aug 1, 2017·2 cites·16 claims
- 0969US7531668B22-arylcarboxamide-nitrogenous heterocycle compoundBANYU PHARMA CO LTD·Filed 2005·Granted May 12, 2009·1 cites·17 claims
- 1067US12459933B2Compounds and methods of use thereof as antibacterial agentsMERCK SHARP & DOHME LLC·Filed 2020·Granted Nov 4, 2025·0 cites·32 claims
- 1164US7485647B22-aminoquinoline derivativesBANYU PHARMA CO LTD·Filed 2004·Granted Feb 3, 2009·2 cites·11 claims
- 1264US2021061777A1Oxazolidinone compounds and methods of use thereof as antibacterial agentsMERCK SHARP & DOHME·Filed 2020·Application pending·0 cites
- 1362US12435077B2Oxazolidinone compound and methods of use thereof as an antibacterial agentMERCK SHARP & DOHME LLC·Filed 2021·Granted Oct 7, 2025·0 cites·24 claims
- 1462US11161819B2Substituted tetrahydroisoquinoline compounds useful as GPR120 agonistsMERCK SHARP & DOHME·Filed 2020·Granted Nov 2, 2021·0 cites·17 claims
- 1558US2025084062A1Substituted quinoline derivativeASTELLAS PHARMA INC·Filed 2022·Application pending·0 cites
- 1656US2024158412A1Ubiquitin-specific protease 7 (usp7) inhibitors and uses thereofFAXIAN THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 1755US10144741B2Nargenicin compounds and uses thereof as antibacterial agentsMERCK SHARP & DOHME·Filed 2018·Granted Dec 4, 2018·0 cites·13 claims
- 1854US2019161448A1Substituted tetrahydroisoquinoline compounds useful as gpr120 agonistsMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 1952US9944654B2Nargenicin compounds and uses thereof as antibacterial agentsMERCK SHARP & DOHME·Filed 2015·Granted Apr 17, 2018·0 cites·15 claims
- 2051US10752621B2Oxazolidinone compounds and methods of use thereof as antibacterial agentsMERCK SHARP & DOHME·Filed 2018·Granted Aug 25, 2020·0 cites·16 claims
- 2150US2011124674A15/5-or 5/6-membered condensed ring cycloalkylamine derivativeKISHINO HIROYUKI·Filed 2009·Application pending·0 cites
- 2249US2011071129A1Spirodiamine-diaryl ketoxime derivativeANDO MAKOTO·Filed 2009·Application pending·0 cites
- 2347US12473284B2Small molecule inhibitors of ULK1MEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Nov 18, 2025·0 cites·18 claims
- 2447US12365656B2Oxazolidinone compounds and methods of use thereof as antibacterial agentsMERCK SHARP & DOHME LLC·Filed 2019·Granted Jul 22, 2025·0 cites·17 claims
- 2546US9650375B2Indole derivatives useful as anti-diabetic agentsMERCK SHARP & DOHME·Filed 2014·Granted May 16, 2017·0 cites·19 claims
- 2644US11339156B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME·Filed 2018·Granted May 24, 2022·0 cites·11 claims
- 2744US2011015198A1Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonismBANYU PHARMACEUTICAL CO INC·Filed 2009·Application pending·0 cites
- 2843US2018290987A1Oxazolidinone compounds and methods of use thereof as antibacterial agentsMANDAL MIHIR B·Filed 2016·Application pending·0 cites
- 2941US2010324049A1Diaryl ketimine derivative having antagonism against melanin-concentrating hormone receptorANDO MAKOTO·Filed 2008·Application pending·0 cites
- 3041US2009247560A1Diaryl ketimine derivativeBANYU PHARMA CO LTD·Filed 2007·Application pending·0 cites
- 3141US2017275298A1Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2015·Application pending·0 cites
- 3237US10160751B2Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2016·Granted Dec 25, 2018·0 cites·14 claims
- 3334US10208064B2Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2015·Granted Feb 19, 2019·0 cites·9 claims
- 3432US2012316200A1Pyridone derivativesLIN LINUS S·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Takao Suzuki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →